These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride. Niznik HB; Guan JH; Neumeyer JL; Seeman P Mol Pharmacol; 1985 Feb; 27(2):193-9. PubMed ID: 3969068 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states. George SR; Watanabe M; Seeman P J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204 [TBL] [Abstract][Full Text] [Related]
4. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. Grigoriadis D; Seeman P J Neurochem; 1985 Jun; 44(6):1925-35. PubMed ID: 3157782 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand. Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586 [TBL] [Abstract][Full Text] [Related]
10. Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors. Terai M; Usuda S; Kuroiwa I; Noshiro O; Maeno H Jpn J Pharmacol; 1983 Aug; 33(4):749-55. PubMed ID: 6138453 [TBL] [Abstract][Full Text] [Related]
11. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations. Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872 [TBL] [Abstract][Full Text] [Related]
12. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs]. Kobayashi T; Shimizu H; Toru M Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198 [TBL] [Abstract][Full Text] [Related]
13. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2. Hatano K; Ishiwata K; Kawashima K; Hatazawa J; Itoh M; Ido T J Nucl Med; 1989 Apr; 30(4):515-22. PubMed ID: 2567779 [TBL] [Abstract][Full Text] [Related]
14. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917 [TBL] [Abstract][Full Text] [Related]
15. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. Urwyler S; Markstein R J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868 [TBL] [Abstract][Full Text] [Related]
16. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Onali P; Olianas MC; Gessa GL Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor. Niznik HB; Otsuka NY; Dumbrille-Ross A; Grigoriadis D; Tirpak A; Seeman P J Biol Chem; 1986 Jun; 261(18):8397-406. PubMed ID: 3522568 [TBL] [Abstract][Full Text] [Related]
18. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. Hamblin MW; Leff SE; Creese I Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712 [TBL] [Abstract][Full Text] [Related]
19. Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics. Assié MB; Sleight AJ; Koek W Eur J Pharmacol; 1993 Jun; 237(2-3):183-9. PubMed ID: 7689973 [TBL] [Abstract][Full Text] [Related]